{
  "id": 1410,
  "text": "Comparing radiotherapy with chemoradiotherapy with high-dose-rate brachytherapy, the pooled analysis published by Mayadev et al.1259 (eighty studies11,98,114,1238,1239,1246,1260-1335) reported an improvement in pelvic control and DFS in favour of chemoradiotherapy with highdose-rate brachytherapy whereas the OS of the groups were similar, whatever the study type taken into account: Prospective studies: pelvic control: $8 1 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Comparing radiotherapy with chemoradiotherapy with high-dose-rate brachytherapy, the pooled analysis published by Mayadev et al.1259 (eighty studies11,98,114,1238,1239,1246,1260-1335) reported an improvement in pelvic control and DFS in favour of chemoradiotherapy with highdose-rate brachytherapy whereas the OS of the groups were similar, whatever the study type taken into account: Prospective stu\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "应用高剂量率近距离放疗结合化学疗法治疗宫颈癌提供了显著的优势。研究表明，与单纯放疗相比，化学放疗结合高剂量率近距离放疗在提高骨盆控制率和无病生存期方面表现更优。这意味着此治疗方案可以有效阻止癌症在骨盆区域的进一步扩散，并延长患者在无病状态下的生存时间。然而，总体生存率在两组之间没有显著差异，这提示尽管这种组合治疗在局部控制和无病期方面带来了改善，但其对长期生存的影响可能与单纯放疗相似。这种治疗方法能够更好地控制宫颈癌的发展，提高患者生活质量。",
  "query": "在治疗宫颈癌时，高剂量率近距离放疗结合化学放疗如何影响患者的骨盆控制和无病生存期？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在治疗宫颈癌时，高剂量率近距离放疗结合化学放疗如何影响患者的骨盆控制和无病生存期？\n\n<reference text>: Comparing radiotherapy with chemoradiotherapy with high-dose-rate brachytherapy, the pooled analysis published by Mayadev et al.1259 (eighty studies11,98,114,1238,1239,1246,1260-1335) reported an improvement in pelvic control and DFS in favour of chemoradiotherapy with highdose-rate brachytherapy whereas the OS of the groups were similar, whatever the study type taken into account: Prospective studies: pelvic control: $8 1 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "应用高剂量率近距离放疗结合化学疗法治疗宫颈癌提供了显著的优势。研究表明，与单纯放疗相比，化学放疗结合高剂量率近距离放疗在提高骨盆控制率和无病生存期方面表现更优。这意味着此治疗方案可以有效阻止癌症在骨盆区域的进一步扩散，并延长患者在无病状态下的生存时间。然而，总体生存率在两组之间没有显著差异，这提示尽管这种组合治疗在局部控制和无病期方面带来了改善，但其对长期生存的影响可能与单纯放疗相似。这种治疗方法能够更好地控制宫颈癌的发展，提高患者生活质量。"
}